The 9th International AIDS Science Conference (IAS 2017), organized by the International AIDS Society, took place in Paris, France this week. Of particular interest are the results of several PrEP studies, including a demonstration project conducted by the Desmond Tutu HIV Foundation, exploring the feasibility of PrEP for adolescents and young women in South Africa. DF/Net Research is proud to support the data management needs of our clients and partners …Read More ›
Registration for DFUG 2017 is officially open! Click here for more details. We look forward to seeing you in Orlando, FL Sept. 27 – Sept. 29th.
Happy International Women’s Day to all women across the globe. A special thanks to the brilliant women who help make this company a success!
The 23rd annual DataFax/DFdiscover User Group meeting will take place September 27-29, 2017 in Orlando, Florida, USA at the JW Marriott Orlando Grande Lakes.
DF/Net is pleased to announce our selection as one of five preferred providers to the Global Health Clinical Consortium (GHCC). DF/Net provides clinical trial data management software and services for biotech, pharmaceutical, non-profit and academic research organizations worldwide.
We are pleased to announce the new name for DataFax. The 2016.X version will be the last release with the name DataFax…CLICK ABOVE TO READ MORE.
Join Our Team! Founded in 2004, DF/Net Research, Inc. is an equal opportunity employer providing data management and data analytics services for international, academic, and non-profit organizations performing clinical trials and research to advance global health. DF/Net Research also owns, develops, and licenses DataFax, a proven hybrid paper and electronic data capture (EDC) software system designed specifically for clinical research in highly regulated industries. DF/Net is comprised of nine collaborative …Read More ›
DF/Net and DataFax-managed studies and research have been featured in recent news — click here for more information and links.
January 2015. After a decade of research and grants from the Gates Foundation and the Department of Defense, Seattle BioMed’s novel anti-malarial vaccine strategy will be put to the test in an effort to combat a disease that is still responsible for half a deaths per year around the world. Project leader Stefan Kappe and his team have used genetic engineering to remove mosquito genes crucial to the parasite’s development. …Read More ›
From Scientific American, October 27, 2014. The World Health Organization (WHO) announced plans on October 24 to produce millions of doses of two experimental Ebola vaccines by the end of 2015. Hundreds of thousands of doses should be available to help affected countries before the end of June, the WHO said at the conclusion of a meeting in Geneva. Vaccine makers, high-level government representatives, and regulatory and other bodies gathered …Read More ›